VALUE DRIVEN PHARMACEUTICALS

Serial Number 85253114
606

Registration Progress

Application Filed
Feb 28, 2011
Under Examination
Sep 13, 2011
Approved for Publication
Jul 19, 2011
Published for Opposition
Jul 19, 2011
Registered

Trademark Image

VALUE DRIVEN PHARMACEUTICALS

Basic Information

Serial Number
85253114
Filing Date
February 28, 2011
Published for Opposition
July 19, 2011
Abandonment Date
October 20, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 20, 2014
Classes
005

Rights Holder

Heritage Pharmaceuticals Inc.

03
Address
105 Fieldcrest Avenue, Suite 100
Edison, NJ 08837

Ownership History

Heritage Pharmaceuticals Inc.

Original Applicant
03
Edison, NJ

Heritage Pharmaceuticals Inc.

Owner at Publication
03
Edison, NJ

Legal Representation

Attorney
Barry S. White

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

30 events
Date Code Type Description Documents
Oct 20, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 20, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Mar 22, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 21, 2014 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 13, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 13, 2014 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 20, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 19, 2013 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 12, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 12, 2013 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 14, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 13, 2013 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 12, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 12, 2013 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 15, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 14, 2012 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 11, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 11, 2012 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 31, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 30, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 30, 2012 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 12, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 12, 2012 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 13, 2011 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 19, 2011 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 19, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 3, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 1, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 3, 2011 NWAP I NEW APPLICATION ENTERED Loading...
Mar 3, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
Full line of neurological, central nervous system, anti-inflammatory, cardiovascular, renal, anti-microbial, anti-neoplastic, immunomodulatory, hematopoietic, anticoagulant, thrombolytic, antiplatelet, estrogenic, progestin, androgen, thyroid, anti-thyroid, ophthalmic, histamine H2 receptor antagonist, proton pump antagonist, anti-emetic, anti-convulsant, anti-asthmatic and anti-diabetic pharmaceutical preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"PHARMACEUTICALS"